Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 3
1997 3
1998 3
1999 1
2000 1
2001 2
2002 3
2003 1
2004 5
2005 3
2007 3
2008 4
2009 9
2010 5
2011 5
2012 11
2013 8
2014 6
2015 5
2016 9
2017 3
2018 10
2019 4
2020 2
2021 1
2022 6
2023 7
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Free article. Clinical Trial.
Mast Cell Disorders.
Katial R. Katial R. Immunol Allergy Clin North Am. 2023 Nov;43(4):xiii. doi: 10.1016/j.iac.2023.08.001. Immunol Allergy Clin North Am. 2023. PMID: 37758414 No abstract available.
Eosinophilic Gastrointestinal Diseases.
Katial R. Katial R. Immunol Allergy Clin North Am. 2024 May;44(2):xvii-xviii. doi: 10.1016/j.iac.2024.01.012. Epub 2024 Feb 14. Immunol Allergy Clin North Am. 2024. PMID: 38575234 No abstract available.
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators. Nair P, et al. N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22. N Engl J Med. 2017. PMID: 28530840 Free article. Clinical Trial.
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators. Bel EH, et al. N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199060 Free article. Clinical Trial.
THE AUTHORS RESPOND.
Xu X, Katial R, Schaefer C, Szende A, Genofre E, Chung Y. Xu X, et al. Among authors: katial r. J Manag Care Spec Pharm. 2024 Apr;30(4):398-399. doi: 10.18553/jmcp.2024.30.4.398. J Manag Care Spec Pharm. 2024. PMID: 38555629 Free PMC article. No abstract available.
Venom Allergy.
Stitt J, Katial R. Stitt J, et al. Among authors: katial r. J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):184-5; quiz 186. doi: 10.1016/j.jaip.2015.09.016. J Allergy Clin Immunol Pract. 2016. PMID: 26772932 No abstract available.
124 results